Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice

Peptides

Volumn 28, Issue 3, 2007, Pages 636-642

  Joppa, M A ^a   Gogas, K R ^a   Foster, A C ^a   Markison, S ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

AgRP; Anorexia; Cytokine; Feeding; Melanocortin; Tumor

Indexed keywords

AGOUTI RELATED PROTEIN; MELANOCORTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACHEXIA; CLINICAL FEATURE; COLON ADENOCARCINOMA; COLON TUMOR; CONTROLLED STUDY; DRUG INFUSION; FOOD INTAKE; LATERAL BRAIN VENTRICLE; MALE; MOUSE; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; TUMOR CELL LINE; WEIGHT GAIN; WEIGHT REDUCTION;

ADENOCARCINOMA; ANIMALS; BODY WEIGHT; CACHEXIA; CELL LINE, TUMOR; COLONIC NEOPLASMS; EATING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; RADIATION INJURIES, EXPERIMENTAL; RECEPTORS, MELANOCORTIN;

AGOUTI; ANIMALIA; MURINAE; MUS;

EID: 33846807457     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.11.021     Document Type: Article

References (43)

1. Brown K.S., Gentry R.M., and Rowland N.E. Central injection in rats of alpha-melanocyte-stimulating hormone analog: effects on food intake and brain Fos. Regul Pept 78 (1998) 89-94
2. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat Neurosci 8 (2005) 571-578
3. Darling G., Fraker D.L., Jensen J.C., Gorschboth C.M., and Norton J.A. Cachectic effects of recombinant human tumor necrosis factor in rats. Cancer Res 50 (1990) 4008-4013
4. Dewys W.D., Begg C., Lavin P.T., Band P.R., Bennett J.M., Bertino J.R., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69 (1980) 491-497
5. Farooqi I.S., Keogh J.M., Yeo G.S., Lank E.J., Cheetham T., and O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348 (2003) 1085-1095
6. Gordon J.N., Green S.R., and Goggin P.M. Cancer cachexia. QJM 98 (2005) 779-788
7. Goto K., Inui A., Takimoto Y., Yuzuriha H., Asakawa A., Kawamura Y., et al. Acute intracerebroventricular administration of either carboxyl-terminal or amino-terminal fragments of agouti-related peptide produces a long-term decrease in energy expenditure in rats. Int J Mol Med 12 (2003) 379-383
8. Grill H.J., Ginsberg A.B., Seeley R.J., and Kaplan J.M. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J Neurosci 18 (1998) 10128-10135
9. Hagan M.M., Rushing P.A., Pritchard L.M., Schwartz M.W., Strack A.M., Van Der Ploeg L.H., et al. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol Regul Integr Comp Physiol 279 (2000) R47-R52
10. Hanada T., Toshinai K., Kajimura N., Nara-Ashizawa N., Tsukada T., Hayashi Y., et al. Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochem Biophys Res Commun 301 (2003) 275-279
11. Huang Q.H., Hruby V.J., and Tatro J.B. Role of central melanocortins in endotoxin-induced anorexia. Am J Physiol 276 (1999) R864-R871
12. Joppa M.A., Ling N., Chen C., Gogas K.R., Foster A.C., and Markison S. Central administration of peptide and small molecule MC4 receptor antagonists induce hyperphagia in mice and attenuate cytokine-induced anorexia. Peptides 26 (2005) 2294-2301
13. Kotler D.P. Cachexia. Ann Intern Med 133 (2000) 622-634
14. Krude H., Biebermann H., Schnabel D., Tansek M.Z., Theunissen P., Mullis P.E., et al. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 88 (2003) 4633-4640
15. Lawrence C.B., and Rothwell N.J. Anorexic but not pyrogenic actions of interleukin-1 are modulated by central melanocortin-3/4 receptors in the rat. J Neuroendocrinol 13 (2001) 490-495
16. Leibovich S.J., Polverini P.J., Shepard H.M., Wiseman D.M., Shively V., and Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-[alpha]. Nature 329 (1987) 630-632
17. Markison S., Foster A.C., Chen C., Brookhart G.B., Hesse A., Hoare S.R., et al. The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule melanocortin-4 receptor antagonist. Endocrinology 146 (2005) 2766-2773
18. Marks D.L., Ling N., and Cone R.D. Role of the central melanocortin system in cachexia. Cancer Res 61 (2001) 1432-1438
19. McMinn J.E., Wilkinson C.W., Havel P.J., Woods S.C., and Schwartz M.W. Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. Am J Physiol Regul Integr Comp Physiol 279 (2000) R695-R703
20. Murphy B., Nunes C.N., Ronan J.J., Harper C.M., Beall M.J., Hanaway M., et al. Melanocortin mediated inhibition of feeding behavior in rats. Neuropeptides 32 (1998) 491-497
21. Nakagoe T., Tsuji T., Sawai T., Tanaka K., Hidaka S., Shibasaki S., et al. Increased serum levels of interleukin-6 in malnourished patients with colorectal cancer. Cancer Lett 202 (2003) 109-115
22. Nara-Ashizawa N., Tsukada T., Maruyama K., Akiyama Y., Kajimura N., Nagasaki K., et al. Hypothalamic appetite-regulating neuropeptide mRNA levels in cachectic nude mice bearing human tumor cells. Metabolism 50 (2001) 1213-1219
23. Negri D.R., Mezzanzanica D., Sacco S., Gadina M., Benigni F., Cajola L., et al. Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours. Cytokine 15 (2001) 27-38
24. Nicholson J.R., Kohler G., Schaerer F., Senn C., Weyermann P., and Hofbauer K.G. Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing mice. J Pharmacol Exp Ther 317 (2006) 771-777
25. Nisoli E., Briscini L., Tonello C., De Giuli-Morghen C., and Carruba M.O. Tumor necrosis factor-alpha induces apoptosis in rat brown adipocytes. Cell Death Differ 4 (1997) 771-778
26. Ollmann M.M., Wilson B.D., Yang Y.K., Kerns J.A., Chen Y., Gantz I., et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278 (1997) 135-138
27. Pelleymounter M.A., Joppa M., Carmouche M., Cullen M.J., Brown B., Murphy B., et al. Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF. J Pharmacol Exp Ther 293 (2000) 799-806
28. Plata-Salaman C.R. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 16 (2000) 1009-1012
29. Plata-Salaman C.R., Ilyin S.E., and Gayle D. Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells. Am J Physiol 275 (1998) R566-R573
30. Rossi M., Kim M.S., Morgan D.G., Small C.J., Edwards C.M., Sunter D., et al. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 139 (1998) 4428-4431
31. Small C.J., Kim M.S., Stanley S.A., Mitchell J.R., Murphy K., Morgan D.G., et al. Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes 50 (2001) 248-254
32. Small C.J., Liu Y.L., Stanley S.A., Connoley I.P., Kennedy A., Stock M.J., et al. CNS administration of Agouti-related protein (Agrp) reduces energy expenditure. Int J Obes Relat Metab Disord 27 (2003) 530-533
33. Strassmann G., Fong M., Kenney J.S., and Jacob C.O. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89 (1992) 1681-1684
34. Tanaka Y., Eda H., Tanaka T., Udagawa T., Ishikawa T., Horii I., et al. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res 50 (1990) 2290-2295
35. Tisdale M.J. Cachexia in cancer patients. Nat Rev Cancer 2 (2002) 862-871
36. Vaisse C., Clement K., Guy-Grand B., and Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 20 (1998) 113-114
37. Van Cutsem E., and Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9 Suppl 2 (2005) S51-S63
38. Vos T.J., Caracoti A., Che J.L., Dai M., Farrer C.A., Forsyth N.E., et al. Identification of 2-[2-[2-(5-bromo-2-methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1H-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model. J Med Chem 47 (2004) 1602-1604
39. Wang Z., Corey E., Hass G.M., Higano C.S., True L.D., Wallace Jr. D., et al. Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia. Int J Cancer 105 (2003) 123-129
40. Wirth M.M., and Giraudo S.Q. Agouti-related protein in the hypothalamic paraventricular nucleus: effect on feeding. Peptides 21 (2000) 1369-1375
41. Yang Y.K., Thompson D.A., Dickinson C.J., Wilken J., Barsh G.S., Kent S.B., et al. Characterization of Agouti-related protein binding to melanocortin receptors. Mol Endocrinol 13 (1999) 148-155
42. Yasuda T., Masaki T., Kakuma T., and Yoshimatsu H. Hypothalamic melanocortin system regulates sympathetic nerve activity in brown adipose tissue. Exp Biol Med (Maywood) 229 (2004) 235-239
43. Yeo G.S., Farooqi I.S., Aminian S., Halsall D.J., Stanhope R.G., and O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 20 (1998) 111-112